Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020437 (
hypercalcemia
)
10,293
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Patients with rhabdomyolysis (RBD) and
acute renal failure
(
ARF
) are hypocalcemic during the oliguric phase of
ARF
and over 30% develop
hypercalcemia
during the diuretic phase. The present study examined the factors underlying these derangements in calcium metabolism in 15 patients: 7 with RBD and
ARF
, 4 with RBD only, and 4 with
ARF
only. All patients had hypocalcemia on admission and the hypocalcemia was more pronounced in those with RBD and
ARF
. All patients with RBD independent of the presence or absence of
ARF
had calcium deposition in soft tissues as documented by technetium-99 scan. In 4 patients with RBD and
ARF
,
hypercalcemia
developed during the diuretic phase at a time when Serum PTH levels were undetectable. Only patients with RBD and
ARF
had a significant increase in serum levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D [1,25(OH)2D] during the diuretic phase and both the increments in and the levels of 1,25(OH)2D were significantly greater in those who were hypercalcemic. The data indicate that 1) hypocalcemia occurs in RBD independent of
ARF
and is most likely related to calcium deposition in injured tissues, and 2) elevation in serum levels of 1,25(OH)2D plays an important role in the genesis of
hypercalcemia
during the diuretic phase of patients with RBD and
ARF
. Our observations suggest that extrarenal production of 1,25(OH)2D may occur in these patients, and/or that the renal production of 1,25(OH)2D may not be so tightly controlled as it is in normal subjects.
...
PMID:Hypocalcemia and hypercalcemia in patients with rhabdomyolysis with and without acute renal failure. 301 37
The case of a 27 year old patient with IgG-lambda-myeloma is reported. Examination revealed
hypercalcemia
and
acute renal failure
. The patient died of heart failure two days after diagnosis. Autopsy revealed an extensive calcification of the inner organs, in particular the heart.
...
PMID:[Fulminating course of IgG plasmacytoma at a young age]. 308 20
A 53-year-old male with Bence Jones lambda myeloma developed
hypercalcemia
and
acute renal failure
(calcium 14.4 mg/dl, BUN 40 mg/dl, creatinine 3.0 mg/dl) after initial response to chemotherapy. A 99mTc-MDP bone scan revealed unusual isotope accumulation in the left hypochondrium. Extensive calcium deposition was confirmed in the gastric mucosa in the postmortem examination. Detection of gastric calcification by a bone scan is very rare. Only two cases of gastric calcification visualized on bone scans can be found in the literature, one with multiple myeloma) and one in Hodgkin's disease).
...
PMID:Metastatic calcification in the stomach demonstrated by a bone scan in Bence Jones lambda myeloma. 310 83
Persistent
hypercalcaemia
developed in a 26-year-old man after rhabdomyolysis-induced
acute renal failure
. Although several serum parathyroid values were normal following recovery of renal function, primary hyperparathyroidism was suspected after 9 months of prolonged
hypercalcaemia
. A single parathyroid adenoma was removed and serum calcium as well as serum parathyroid hormone returned to normal values. The persistence of increased serum calcium concentrations after rhabdomyolysis-induced
acute renal failure
should lead one to consider other causes of
hypercalcaemia
, and particularly primary hyperparathyroidism.
...
PMID:Parathyroid adenoma causing persistent hypercalcaemia after rhabdomyolysis-induced acute renal failure. 311 Jun 63
A case of fatal hepato-renal failure occurring during mithramycin treatment is reported. A 64 year-old female patient was admitted to hospital in a state of
acute renal failure
. She also presented with
hypercalcaemia
and bilateral pulmonary metastases. She had been operated on 10 years previously of a parathyroid cancer. Despite treatment with mithramycin (total dose 8.25 mg) and haemodialysis, the
hypercalcaemia
returned; it was then decided to remove the secretory lung metastases (parathormone 420 micrograms X ml-1). 48 hours before surgery, the patient was again given 1.25 mg mithramycin. Immediately after surgery, she developed hepatic failure with massive cell destruction and anuria. The patient died 48 h after the operation. The hepatic and renal complications of mithramycin are discussed.
...
PMID:[Acute fatal hepatorenal failure during treatment with mithramycin]. 316 Feb 68
We describe the case of a child aged 11 months with vitamin D intoxication and
hypercalcemia
, who developed
acute renal failure
and dyspnea. Chest X-rays showed interstitial changes compatible with either pulmonary alveolar proteinosis or pulmonary edema. The
hypercalcemia
suggested the possibility of metastatic calcifications of the lung. This hypothesis was subsequently confirmed by the progressive disappearance of pulmonary findings as calcemic levels returned to normal values... Our report emphasize the opportunity of studying the respiratory system in each patient with
hypercalcemia
, whichever the etiology may be.
...
PMID:[Pulmonary calcification in vitamin D poisoning in an infant]. 324 59
The effect of 1,25(OH)2 vitamin D3-induced
hypercalcemia
on the course of aminoglycoside nephrotoxicity in the rat was studied. Daily gentamicin, 100 mg/kg body weight, was administered subcutaneously concomitant with 1,25(OH)2 vitamin D3, 50 ng s.c. to male Sprague-Dawley rats. This group was compared to rats injected with gentamicin alone, 1,25(OH)2 vitamin D3 alone, and an ethanol vehicle as a control. Structural and functional parameters of
acute renal failure
were assessed following 4, 6 and 7 days of treatment. Severe morphologic evidence of tubular injury was documented on day 6 in the group injected with gentamicin and 1,25(OH)2 vitamin D3. Correlative functional and metabolic evidence of tubular cell deterioration occurred in this group on day 7 as represented by an elevated blood urea nitrogen (BUN), 198 +/- 14 mg/dl (p less than 0.001 compared to all other groups), a heightened mean renal cortical homogenate calcium, 1,028.3 +/- 304.8 nmol/mg protein (p less than 0.05 or better compared to all other groups), and significantly increased mean cortical mitochondrial calcium content, 796.3 +/- 116.5 nmol/mg protein (p less than 0.01 in relation to all other groups). Elevated total serum calcium to a level of 11.9 +/- 0.2 mg/dl (p less than 0.001 compared to control group) developed in the gentamicin/1,25(OH)2 vitamin D3 group on day 4, 2 days prior to pronounced structural damage, and continued to be elevated through day 7. No difference in serum phosphorus levels, however, developed between control and gentamicin-plus-vitamin-D-treated animals except on day 7 when severe renal failure developed in this group.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Potentiation of aminoglycoside nephrotoxicity by vitamin-D-induced hypercalcemia. 338 67
Alterations in the calcium metabolism are a characteristic paraclinical finding in patients with oliguric
acute renal failure
associated with rhabdomyolysis. A 20-year-old male operated on under general anesthesia developed non-oliguric
acute renal failure
due to malignant hyperthermia with rhabdomyolysis (urine myoglobin greater than 20,000 nmol/l; reference range less than 0.85 nmol/l). On the 20th postoperative day
hypercalcemia
was found, reaching a maximum serum level of 3.74 mmol/l (reference range 2.18-2.65 mmol/l) on the 27th postoperative day. Delayed
hypercalcemia
in non-oliguric
acute renal failure
associated with rhabdomyolysis has not been reported previously. This case suggests that prolonged control of the serum calcium level should be performed in patients with rhabdomyolysis, even in the absence of oliguria.
...
PMID:Delayed hypercalcemia after non-oliguric acute renal failure associated with rhabdomyolysis. 341 9
Hypercalcemia
during the recovery phase of renal function is a relatively common complication of rhabdomyolysis-associated
acute renal failure
. The cause is unclear but it has been suggested recently that both hyperparathyroidism and high levels of calcitriol are implicated. We present evidence which does not support these hypotheses.
...
PMID:Hypercalcemia during resolution of acute renal failure associated with rhabdomyolysis: evidence for suppression of parathyroid hormone and calcitriol. 346 94
A 89-year-old woman showed transient and mild
hypercalcemia
(11.0 mg/dl) at the phase of recovery from
acute renal failure
. Serum PTH level elevated to 2.1 ng/ml when
hypercalcemia
was observed, and decreased to 1.1 ng/ml. Autopsy study revealed the bleeding within parathyroid adenoma. The transient and mild
hypercalcemia
seen in the patient was considered as the result of the bleeding within parathyroid adenoma. This unusual manifestation of parathyroid adenoma, bleeding, usually causes hypercalcemic crisis. The mild
hypercalcemia
observed in this patient despite of bleeding into parathyroid adenoma might be due to old age of the patient and the existence of renal failure in the patient.
...
PMID:Hypercalcemia due to spontaneous hemorrhage in a parathyroid adenoma during recovery from acute renal failure. 371 66
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>